BLUEDIAMOND ZYGOMA extends MegaGen’s implant portfolio into zygomatic remedy for complicated full-arch rehabilitation in sufferers with serious maxillary atrophy.
BLUEDIAMOND ZYGOMA builds on MegaGen’s revel in in implant design and mechanical balance. The gadget helps each fast and not on time loading protocols relying on scientific stipulations. Consistent with MegaGen, its advent additionally extends the corporate’s One-Day Implant philosophy into extra complicated full-arch packages.
MegaGen is positioning BLUEDIAMOND ZYGOMA as a part of a virtual full-arch workflow encompassing prognosis, remedy making plans, surgical treatment and prosthetic remedy. The corporate mentioned it intends to additional increase full-arch answers that incorporate typical, zygomatic and pterygoid implant approaches in line with residual bone and anatomical stipulations, supported by way of virtual workflows and scientific training.
Debut in Chicago
The following day, MegaGen will officially introduce BLUEDIAMOND ZYGOMA to the USA marketplace throughout its 2026 North The us Medical Assembly in Chicago. The 2-day tournament will function lectures and hands-on training in full-arch rehabilitation, together with a devoted workshop on zygomatic and pterygoid answers for complicated circumstances. Extra details about the assembly programme will also be discovered right here.
:sharpen(level=0):output(format=jpeg)/up/dt/2025/01/ICD_1920x1080.jpg?w=120&resize=120,86&ssl=1 "ICD’s World Oral Well being Management Institute introduced")